《新股消息》商湯(00020.HK)延遲上市並退回申請款項 傳目標最快年底前完成上市
商湯集團(00020.HK)宣佈,全球發售及上市將會延遲,預期將刊發補充招股章程,更新上市時間表、香港發售股份的相關申請程序及其他相關資料,公司仍致力儘快完成全球發售及上市。所有申請股款將不計利息悉數退還予所有申請人,而申請股款應計或賺取的所有利息將捐贈予香港公益金。
據知情人士表示,商湯對在港上市計劃仍然堅定不移,目標最快今年底前完成上市,又指投資者對IPO興趣未減。
商湯原定於本週五(17日)上市,惟美國財政部於本月10日將商湯列入「非SDN中國軍工複合體企業名單」,令IPO有所推遲。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.